5.23

0.19% 0.01

After Hours: 5.23

Molecular Partners Ag Adr (MOLN)

Overview News Price History Discussions Forecast

Molecular Partners Ag Adr stock is traded at $5.23, with a volume of 5,482. It is up +0.19% in the last 24 hours and up +4.81% over the past month. Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Previous Close:

$5.22

Open:

$5.24

24h Volume:

5,482

Relative Volume:

0.24

Market Cap:

$192.43M

Revenue:

$7.80M

Net Income/Loss:

$-69.02M

P/E Ratio:

-2.4424

EPS:

-2.1413

Net Cash Flow:

$-66.61M

1W Performance:

-1.84%

1M Performance:

+4.81%

6M Performance:

-17.96%

1Y Performance:

+12.47%

1-Day Range:

$5.23

$5.24

1-Week Range:

$5.22

$5.41

52-Week Range:

$3.32

$12.70

Molecular Partners Ag Adr Stock (MOLN) Company Profile

Name

Molecular Partners Ag Adr

Sector

Healthcare (1178)

Industry

Biotechnology (678)

Phone

Address

Employee

167

Twitter

Next Earnings Date

2024-08-26

Latest SEC Filings

MOLN's Discussions on Twitter

Compare MOLN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MOLN Molecular Partners Ag Adr	5.23	192.43M	7.80M	-69.02M	-66.61M	-2.1413
VRTX Vertex Pharmaceuticals Inc	438.40	113.67B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	683.08	74.97B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	665.68	40.50B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	277.16	35.95B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	120.88	29.63B	3.30B	-501.07M	1.03B	-2.1146

Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-30-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Aug-29-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
May-25-22	Upgrade	Credit Suisse	Underperform → Neutral
Apr-27-22	Downgrade	Credit Suisse	Neutral → Underperform
Jul-13-21	Initiated	Cowen	Outperform
Jul-12-21	Resumed	SVB Leerink	Outperform